Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 480
Immune Disorders Drugs 201
Drug Discovery 169
Cardiovascular Drugs 159
Infectious Diseases Drugs 138
Biopharmaceuticals 133
Clinical Trials 126
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 84
Hematological Drugs 83
Liver and Kidney Disorders Drugs 81
Lymphoma Drugs 62
Dermatological Drugs 55
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 41
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Pharmaceutical Intermediates 38
Drug Delivery 37
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 33
Infusions and Injectables 30
Liver Cancer Drugs 28
Bladder Cancer Drugs 25
Analgesics 25
Drugs by Therapeutic Area 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Schizophrenia Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Optical Disorders Drugs 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

2,461 Results (Page 67 of 124)
- Relevance
  Sort by

High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma), and Region - Forecast to 2027

 Report
May 2022
270 Pages
Global

From

€4888EUR$4,950USD£4,082GBP

Dermatological Therapeutics Market by Drug Class, Application - Global Forecast 2025-2030

 Report
October 2024
180 Pages
Global

From

€3501EUR$3,545USD£2,923GBP

€3890EUR$3,939USD£3,248GBP

Major Depressive Disorder Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Postpartum Depression Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Schizophrenia Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA: Distribution by Type of Monitoring Method, Bioprocessing Method, Working Volume, Scalability, Key Geographical Regions : Industry Trends and Global Forecasts, 2022-2035

 Report
July 2022
197 Pages
Global

From

€4739EUR$4,799USD£3,957GBP

Central Nervous System Collaboration and Licensing Deals 2019-2024

 Report
October 2024
500 Pages
Global

From

€3945EUR$3,995USD£3,294GBP

Bipolar Disorder Therapeutics Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Ewing Sarcoma Disease - Global Clinical Trials Review, H1, 2021

 Clinical Trials
February 2021
267 Pages
Global

From

€2469EUR$2,500USD£2,061GBP

Idiopathic Pulmonary Fibrosis Market by Drug Type, Distribution Channel, End-User - Global Forecast 2025-2030

 Report
October 2024
195 Pages
Global

From

€3501EUR$3,545USD£2,923GBP

€3890EUR$3,939USD£3,248GBP

Multiple Myeloma Drugs Market 2023-2027

 Report
October 2022
120 Pages
Global

From

€2469EUR$2,500USD£2,061GBP

Waldenstrom's Macroglobulinaemia - Pipeline Insight, 2022

 Clinical Trials
November 2022
80 Pages
Global

From

€1382EUR$1,400USD£1,154GBP

€1975EUR$2,000USD£1,649GBP

Global TCR Therapy Market, 2022-2035: Distribution by Target Indication, Target Antigen, Key Players and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

 Report
December 2022
363 Pages
Global

From

€4739EUR$4,799USD£3,957GBP

Global TIL Therapies Market : Distribution by Target Indication, Key Players and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

 Report
January 2023
315 Pages
Global

From

€4739EUR$4,799USD£3,957GBP

Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis

 Report
April 2024
496 Pages
Global

From

€6907EUR$6,995USD£5,768GBP

Non-Hodgkin's Lymphoma Treatment Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€5924EUR$5,999USD£4,947GBP

Antipsychotic Drugs Market by Therapeutic Class, Application and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030

 Report
September 2021
187 Pages
Global

From

€3665EUR$3,712USD£3,061GBP

Human Microbiome Market: Focus on Therapeutics, Diagnostics and Fecal Microbiota Therapy: Distribution by Type of Molecule, Type of Product, Target Indication, Therapeutic Areas, Supply Channels and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

 Report
April 2022
552 Pages
Global

From

€4739EUR$4,799USD£3,957GBP

T-cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2024

 Drug Pipelines
April 2024
50 Pages
Global

From

€1037EUR$1,050USD£866GBP

€1481EUR$1,500USD£1,237GBP

T-cell lymphoma Market 2022-2026

 Report
August 2022
120 Pages
Global

From

€2469EUR$2,500USD£2,061GBP

2,461 Results (Page 67 of 124)
- 1
- 65
- 66
- 67
- 68
- 69

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.